Image

Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA

Study on brain protein and symptoms in people with unexplained smell loss.

Recruiting
55-75 years
All
Phase N/A

Study Purpose: This study aims to find early signs of Dementia with Lewy bodies (DLB), a brain disorder, by testing people with smell problems, called idiopathic anosmia (iOD). Anosmia means losing the sense of smell.

What We Do: We use a special test named Real-Time Quaking-Induced Conversion (RT-QuIC) to check for bad proteins, called alpha-synuclein, that might cause DLB. This test might help doctors find and help people with early DLB symptoms.

  • **Duration:** The study involves several visits to test for olfactory dysfunction and follow-up checks.
  • **Participant Requirements:** Must be between 55-75 years old without major diseases and able to consent.
  • **Potential Risks:** Participants may experience discomfort from nasal tests but no major risks are expected.

The study involves two parts: one part compares people with smell problems to those without, and the other part checks health records over time. Participants should not have other major health issues. This research might help find new treatments for DLB in the future.

Study details
    Idiopathic Anosmia
    Idiopathic Hyposmia
    Idiopathic Olfactory Dysfunction

NCT05740683

Danish Dementia Research Centre

17 April 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.